Evidence map›Paper›PMID 29118167›Full record

ArticleJournal of clinical microbiology2018

Invasive Disease Caused Simultaneously by Dual Serotypes of Streptococcus pneumoniae.

Kedibone Ndlangisa, Mignon du Plessis, Mushal Allam, Nicole Wolter, Linda de Gouveia, Keith P Klugman, Cheryl Cohen, Rebecca A Gladstone, Anne von Gottberg

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Invasive disease caused simultaneously by two different serotypes of Streptococcus pneumoniae: a microbiological appreciation.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  3. Article
  4. Article
  5. DistinctMicrobial genomics · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kedibone NdlangisaNational Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa kedibonen@nicd.ac.za.
Mignon du PlessisNational Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0001-9186-0679
Mushal AllamNational Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0002-9875-6716
Nicole WolterNational Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
Linda de GouveiaNational Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
Keith P KlugmanSchool of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
Cheryl CohenNational Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
Rebecca A GladstoneInfection Genomics, Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
Anne von GottbergNational Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.

Funding

Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09U01IP001048 · IP · NATIONAL HEALTH LABORATORY SERVICE · PI COHEN, CHERYL · 2016 to 2020
$19.9M
NCIRD CDC HHS U01 IP001048PEPFAR
6 · The paper itself

Abstract

There are at least 98 known pneumococcal serotypes. Invasive pneumococcal disease (IPD) is usually caused by a single serotype, and dual-serotype IPD is rare. To assess factors associated with dual-serotype IPD, patient information obtained through laboratory-based surveillance for IPD from 2005 through 2014 in South Africa was reviewed. Genomes of isolate pairs from coinfected individuals were sequenced to determine their molecular characteristics. For 30 (91%) of 33 patients with dual serotypes, one or both isolates were a pneumococcal conjugate vaccine (PCV13) serotype. Dual-serotype IPD was associated with children <5 years of age (adjusted odds ratio [aOR], 4.7; 95% confidence interval [95% CI], 1.8 to 11.7), underlying illness (other than HIV) (aOR, 2.8; 95% CI, 1.1 to 6.6) and death (aOR, 2.5; 95% CI, 1.08 to 6.09). For each coinfecting pair, isolates were genotypically unrelated, and their genotypes were common among isolates of the same serotype in South Africa. Of 701 accessory genes identified among dual-serotype IPD isolates, four were common between isolate pairs. Coinfecting isolate pairs had different genotypic backgrounds. The association of dual serotypes with death warrants increased awareness of IPD coinfection caused by two or more serotypes.

Indexed as

CoinfectionAdultAged, 80 and overAge FactorsChildChild, PreschoolDNA, BacterialFemaleGenome, BacterialGenotypeHumansInfantInfant, NewbornMaleMiddle AgedPneumococcal InfectionsDNA, BacterialPneumococcal VaccinesVaccines, Conjugatedualinvasivepneumococcalserotype

Identifiers

PMID29118167
PMCPMC5744228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.